Koyfin Home > Directory > Health Care > American Renal Associates > Net Debt / EBITDA

American Renal Associates Net Debt / EBITDA Chart (ARA)

American Renal Associates annual/quarterly Net Debt / EBITDA from 2010 to 2020. Net Debt / EBITDA is a measure of leverage for a company by dividing the Debt less Cash on hand vs. EBITDA.
  • American Renal Associates Net Debt / EBITDA for the quarter ending September 09, 2020 was $3m a -38.46% decrease of -1m year over year
  • American Renal Associates Net Debt / EBITDA for the last 12 months ending September 09, 2020 was $4m a -13.55% decrease of -1m year over year
  • American Renal Associates Annual Net Debt / EBITDA for 2019 was $4m a 13.60% increase of 1m from 2018
  • American Renal Associates Annual Net Debt / EBITDA for 2018 was $4m a 9.68% increase of 0m from 2017
  • American Renal Associates Annual Net Debt / EBITDA for 2017 was $3m a 26.20% increase of 1m from 2016
Other Ratios Metrics:
  • American Renal Associates Total Debt / Capital for the quarter ending September 09, 2018 was $70m a 1.83% increase of 1m year over year
  • American Renal Associates Other Liabilities for the quarter ending September 09, 2018 was $39m a 19.44% increase of 8m year over year
  • American Renal Associates Total Debt / Equity for the quarter ending September 09, 2018 was $228m a 5.77% increase of 13m year over year
View Chart On Koyfin

Quarterly ARA Net Debt / EBITDA Data

09/2020$3m
06/2020$3m
03/2020$7m
12/2019$4m
09/2019$4m
06/2019$4m
03/2019$6m
12/2018$4m
09/2018$3m
06/2018$3m

Annual ARA Net Debt / EBITDA Data

2019$4m
2018$4m
2017$3m
2016$2m
2015$3m
2014$4m
2013$5m
2012$3m
2011$4m
2010$3m